Literature DB >> 12669960

The mean dissolution time depends on the dose/solubility ratio.

Eleni Rinaki1, Aristides Dokoumetzidis, Panos Macheras.   

Abstract

PURPOSE: To investigate the relationship between mean dissolution time (MDT) and dose/solubility ratio (q) using the diffusion layer model.
METHODS: Using the classic Noyes-Whitney equation and considering a finite dose, we derived an expression for MDT as a function of q under various conditions. q was expressed as a dimensionless quantity by taking into account the volume of the dissolution medium. Our results were applied to in vitro and in vivo data taken from literature.
RESULTS: We found that MDT depends on q when q < 1 and is infinite when q > 1 and that the classic expression of MDT = 1/k. where k is the dissolution rate constant, holds only in the special case of q = 1. For the case of perfect sink conditions, MDT was found to be proportional to dose. Using dissolution data from literature with q < 1, we found better estimates of MDT when dependency on dose/ solubility ratio was considered than with the classic approach. Prediction of dissolution limited absorption was achieved for some of the in vivo drug examples examined.
CONCLUSION: The mean dissolution time of a drug depends on dose/ solubility ratio, even when the model considered is the simplest possible. This fact plays an important role in drug absorption when absorption is dissolution limited.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669960     DOI: 10.1023/a:1022652004114

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

Review 1.  Mean time concept and component analysis in pharmacokinetics.

Authors:  D Brockmeier
Journal:  Int J Clin Pharmacol Ther       Date:  1999-11       Impact factor: 1.366

Review 2.  Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.

Authors:  L X Yu; E Lipka; J R Crison; G L Amidon
Journal:  Adv Drug Deliv Rev       Date:  1996-06-12       Impact factor: 15.470

3.  Biopharmaceutics classification system: the scientific basis for biowaiver extensions.

Authors:  Lawrence X Yu; Gordon L Amidon; James E Polli; Hong Zhao; Mehul U Mehta; Dale P Conner; Vinod P Shah; Lawrence J Lesko; Mei-Ling Chen; Vincent H L Lee; Ajaz S Hussain
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

4.  Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation.

Authors:  N D Eddington; P Marroum; R Uppoor; A Hussain; L Augsburger
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

5.  Mixing-tank model for predicting dissolution rate control or oral absorption.

Authors:  J B Dressman; D Fleisher
Journal:  J Pharm Sci       Date:  1986-02       Impact factor: 3.534

6.  In vitro--in vivo correlation, a time scaling problem? Basic techniques for testing equivalence.

Authors:  D Brockmeier; D Voegele; H M von Hattingberg
Journal:  Arzneimittelforschung       Date:  1983

7.  Factors affecting the accuracy of estimated mean absorption times and mean dissolution times.

Authors:  R K Brazzell; S A Kaplan
Journal:  J Pharm Sci       Date:  1983-06       Impact factor: 3.534

8.  Comparison of statistical moment parameters to Cmax and tmax for detecting differences in in vivo dissolution rates.

Authors:  K C Khoo; M Gibaldi; R K Brazzell
Journal:  J Pharm Sci       Date:  1985-12       Impact factor: 3.534

9.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

10.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

View more
  16 in total

1.  Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.

Authors:  Eleni Rinaki; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

2.  Evaluation of the impacts of formulation variables and excipients on the drug release dynamics of a polyamide 6,10-based monolithic matrix using mathematical tools.

Authors:  Oluwatoyin A Adeleke; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Lomas K Tomar; Charu Tyagi; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2013-08-30       Impact factor: 3.246

3.  Identification of biowaivers among Class II drugs: theoretical justification and practical examples.

Authors:  Eleni Rinaki; Aristides Dokoumetzidis; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

4.  Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function.

Authors:  Aristides Dokoumetzidis; Vasiliki Papadopoulou; Panos Macheras
Journal:  Pharm Res       Date:  2006-01-25       Impact factor: 4.200

5.  An Investigation into the Factors Governing Drug Absorption and Food Effect Prediction Based on Data Mining Methodology.

Authors:  Biljana Gatarić; Jelena Parojčić
Journal:  AAPS J       Date:  2019-12-10       Impact factor: 4.009

6.  In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia.

Authors:  Laura C Amann; Michael J Gandal; Robert Lin; Yuling Liang; Steven J Siegel
Journal:  Pharm Res       Date:  2010-04-27       Impact factor: 4.200

7.  Inclusion complex of lurasidone hydrochloride with Sulfobutylether-β-cyclodextrin has enhanced oral bioavailability and no food effect.

Authors:  Jin Wang; Binbin Huang; Jie Dai; Guoguang Chen; Lili Ren
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

8.  Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population Analysis.

Authors:  Carolina Ameijeiras Rodríguez; Sara Carolina Henriques; Aymara Sancho-Araiz; Iñaki F Trocóniz; Luis Almeida; Nuno Elvas Silva
Journal:  Pharm Res       Date:  2021-12-21       Impact factor: 4.200

9.  Effect of cyclodextrin complexation on the aqueous solubility and solubility/dose ratio of praziquantel.

Authors:  Stratos Maragos; Helen Archontaki; Panos Macheras; Georgia Valsami
Journal:  AAPS PharmSciTech       Date:  2009-12-01       Impact factor: 3.246

10.  Formulation of Chewable Tablets Containing Carbamazepine-β-cyclodextrin Inclusion Complex and F-Melt Disintegration Excipient. The Mathematical Modeling of the Release Kinetics of Carbamazepine.

Authors:  Adina Magdalena Musuc; Valentina Anuta; Irina Atkinson; Iulian Sarbu; Vlad Tudor Popa; Cornel Munteanu; Constantin Mircioiu; Emma Adriana Ozon; George Mihai Nitulescu; Mirela Adriana Mitu
Journal:  Pharmaceutics       Date:  2021-06-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.